TITLE

Melanoma of the female urethra

AUTHOR(S)
Papeš, Dino; Altarac, Silvio
PUB. DATE
March 2013
SOURCE
Medical Oncology;Mar2013, Vol. 30 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Primary melanoma of the female urethra is a very rare malignant tumor with high mortality. Due to its rarity, there are no guidelines and recommendations on the diagnosis and treatment of such patients, so we aimed to review the reported cases and case series, their treatment, and outcome. We searched through PubMed for all articles reporting on female urethral melanoma. We found 73 articles (case reports and case series) reporting on 112 patients. There are no clinical trials on the topic due to the rarity of the condition. Median patient age at presentation is 68 years. Due to the late presentation, the prognosis of the disease is poor, and median survival is 16 months, with 5-year survival in around 10 % (12 reported patients). Regarding treatment, most authors use either less radical approach (partial or total urethrectomy) or radical approach (anterior pelvic exenteration). We found no evidence that either of the treatment modalities results with higher survival. In local excision, there are indications that margins less than 2-2.5 cm result in high percentage of local recurrence suggesting that resection width should be at least 2.5 cm. For localized urethral melanoma, local resection with margins of 2.5 cm can be recommended and there is no foundation to support radical surgery in such patients. Chemotherapy and immunotherapy can also recommend. For locally advanced disease, the prognosis is poor, and radical surgery will not improve survival significantly.
ACCESSION #
85859840

 

Related Articles

  • Primary malignant melanoma of the urethra: a systematic analysis of the current literature. El-Safadi, Samer; Estel, Rebecca; Mayser, Peter; Muenstedt, Karsten // Archives of Gynecology & Obstetrics;May2014, Vol. 289 Issue 5, p935 

    Background: Primary malignant melanoma of the urethra is a rare tumour that most commonly affects the meatus and distal urethra. General prognosis seems to be poor. To date, there have been no systematic reviews on this topic. Therefore, we aimed to gain more insight into this rare type of...

  • Checkpoint Kinase 1 Is Overexpressed during HPV16-Induced Cervical Carcinogenesis. Lin, Wei; Chen, Suxiu // Gynecologic & Obstetric Investigation;May2018, Vol. 83 Issue 3, p299 

    Purpose: Cervical cancer is one of the leading causes of cancer death among women worldwide. Checkpoint kinase 1 (Chk1) has a critical role in DNA damage response and cell cycle checkpoint control. Emerging evidence suggests that Chk1 promotes tumor growth. However, whether Chk1 is...

  • Triple Negative Breast Tumors in African-American and Hispanic/Latina Women Are High in CD44+, Low in CD24+, and Have Loss of PTEN. Wu, Yanyuan; Sarkissyan, Marianna; Elshimali, Yahya; Vadgama, Jaydutt V. // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Background:African-American women have higher mortality from breast cancer than other ethnic groups. The association between poor survival and differences with tumor phenotypes is not well understood. The purpose of this study is to assess the clinical significance of (1) Stem cell-like markers...

  • Urethral Advancement Procedure for Reconstruction after Excision of Male Parameatal Melanoma in situ. Kato, Haruaki; Hayashi, Koichi; Saida, Toshiaki; Kontani, Kazuhiko; Nishizawa, Osamu // Urologia Internationalis;Feb2005, Vol. 74 Issue 2, p183 

    We successfully reconstructed the glans penis and external meatus by means of the urethral mobilization and advancement technique for an adult patient with a parameatal lesion of melanoma in situ. Copyright © 2005 S. Karger AG, Basel

  • CUTANEOUS MALIGNANT MELANOMA SURVIVAL: HOW MANY YEARS OF LIFE CAN EARLY DIAGNOSIS SAVE? Fortes, C.; Mastroeni, S.; Concolino, F.; Sera, F.; Forastiere, F.; Abeni, D.; Pasquini, P. // Journal of Epidemiology & Community Health;Aug2004 Supplement 1, Vol. 58, pA80 

    The aim of this study was to evaluate 5 year survival and to investigate the association between melanoma mortality and clinical and histological features. The authors conducted a 5 year cohort study among 1020 patients from Rome, Italy with a single primary cutaneous melanoma diagnosed between...

  • Prognostic Value of [18F]-Fluoro-Deoxy-Glucose PET/CT, S100 or MIA for Assessment of Cancer-Associated Mortality in Patients with High Risk Melanoma. Essler, Markus; Link, Anna; Belloni, Benedetta; Mirceva, Vesna; Souvatzoglou, Michael; Thaler, Markus; Haller, Bernhard; Hein, Ruediger; Krause, Bernd J. // PLoS ONE;2011, Vol. 6 Issue 9, p1 

    Purpose: To assess the prognostic value of FDG PET/CT compared to the tumor markers S100B and melanoma inhibitory activity (MIA) in patients with high risk melanoma. Methods: Retrospective study in 125 consecutive patients with high risk melanoma that underwent FDG PET/CT for restaging....

  • "Small" Melanomas. Kopf, Alfred W.; Rodríguez-Sains, René S.; Rigel, Darrell S.; Friedman, Robert J.; Bart, Robert S.; Grier, W. Robson N.; Mintzis, Midwin M.; Postel, Allen H. // Journal of Dermatologic Surgery & Oncology;Sep82, Vol. 8 Issue 9, p765 

    In a consecutive series of 648 superficial spreading melanomas a significantly better 5-year disease-free survival rate was observed for patients whose primary tumors were 14 mm or less in diameter when compared with those 15 mm or larger in diameter. Other distinguishing features of the group...

  • Mortalidad por cáncer de pulmón en México de 1990 a 2016: efecto edad-periodo-cohorte. Rojas-Martínez, Rosalba; Escamilla-Núñez, Consuelo; Meza, Rafael; Vázquez-Salas, Ruth Argelia; Zárate-Rojas, Emiliano; Lazcano-Ponce, Eduardo // Salud Pública de México;May/Jun2019, Vol. 61 Issue 3, p230 

    Objective. To update information on the mortality trend due to lung cancer in Mexico from 1990 to 2016. Materials and methods. Age-adjusted rates were obtained using the direct method. The percentage of annual change in the mortality of lung cancer was obtained through joinpoint analysis at the...

  • Solute carrier transporters: potential targets for digestive system neoplasms. Xie, Jing; Zhu, Xiao Yan; Liu, Lu Ming; Meng, Zhi Qiang // Cancer Management & Research;Jan2018, Vol. 10, p153 

    Digestive system neoplasms are the leading causes of cancer-related death all over the world. Solute carrier (SLC) superfamily is composed of a series of transporters that are ubiquitously expressed in organs and tissues of digestive systems and mediate specific uptake of small molecule...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics